Tamaki S - Search Results

1

Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.

Kawai T, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kondo T, Takahashi S, Ishimi M, Hakui H, Ozaki T, Sato Y, Seo M, Sakata Y, Fukunami M. Kawai T, et al. Among authors: tamaki s. Am J Cardiol. 2015 Jun 1;115(11):1549-54. doi: 10.1016/j.amjcard.2015.02.058. Epub 2015 Mar 12. Am J Cardiol. 2015. PMID: 25851796

2

Usefulness of spatial dispersion of QRS duration in predicting mortality in patients with mild to moderate chronic heart failure.

Yamada T, Shimonagata T, Misaki N, Asai M, Makino N, Kioka H, Tamaki S, Fukunami M. Yamada T, et al. Among authors: tamaki s. Am J Cardiol. 2004 Oct 1;94(7):960-3. doi: 10.1016/j.amjcard.2004.06.042. Am J Cardiol. 2004. PMID: 15464690

3

Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy.

Yamada T, Node K, Mine T, Morita T, Kioka H, Tamaki S, Tsukamoto Y, Masuda M, Okuda K, Fukunami M. Yamada T, et al. Among authors: tamaki s. Am J Med Sci. 2006 Dec;332(6):361-3. doi: 10.1097/00000441-200612000-00011. Am J Med Sci. 2006. PMID: 17170629

4

Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.

Kioka H, Yamada T, Mine T, Morita T, Tsukamoto Y, Tamaki S, Masuda M, Okuda K, Hori M, Fukunami M. Kioka H, et al. Among authors: tamaki s. Heart. 2007 Oct;93(10):1213-8. doi: 10.1136/hrt.2006.094524. Epub 2007 Mar 7. Heart. 2007. PMID: 17344327 Free PMC article.

5

Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.

Yamada T, Node K, Mine T, Morita T, Kioka H, Tsukamoto Y, Tamaki S, Masuda M, Okuda K, Fukunami M. Yamada T, et al. Among authors: tamaki s. Am Heart J. 2007 Jun;153(6):1055.e1-8. doi: 10.1016/j.ahj.2007.03.027. Am Heart J. 2007. PMID: 17540209 Clinical Trial.

6

Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.

Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M. Masuda M, et al. Among authors: tamaki s. Am J Cardiol. 2007 Sep 1;100(5):781-6. doi: 10.1016/j.amjcard.2007.03.098. Epub 2007 Jun 13. Am J Cardiol. 2007. PMID: 17719320 Clinical Trial.

7

Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.

Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, Masuda M, Okuda K, Iwasaki Y, Yasui T, Hori M, Fukunami M. Tamaki S, et al. J Am Coll Cardiol. 2009 Feb 3;53(5):426-35. doi: 10.1016/j.jacc.2008.10.025. J Am Coll Cardiol. 2009. PMID: 19179201 Free article.

8

Long-term beta-blocker therapy improves diastolic function even without the therapeutic effect on systolic function in patients with reduced ejection fraction.

Tamaki S, Sakata Y, Mano T, Ohtani T, Takeda Y, Kamimura D, Omori Y, Yamamoto K. Tamaki S, et al. J Cardiol. 2010 Sep;56(2):176-82. doi: 10.1016/j.jjcc.2010.04.001. Epub 2010 May 20. J Cardiol. 2010. PMID: 20493661 Free article.

9

Transition from asymptomatic diastolic dysfunction to heart failure with preserved ejection fraction: roles of systolic function and ventricular distensibility.

Aizawa Y, Sakata Y, Mano T, Takeda Y, Ohtani T, Tamaki S, Omori Y, Tsukamoto Y, Hirayama A, Komuro I, Yamamoto K. Aizawa Y, et al. Among authors: tamaki s. Circ J. 2011;75(3):596-602. doi: 10.1253/circj.cj-10-1037. Epub 2011 Jan 27. Circ J. 2011. PMID: 21282875 Free article.

10

Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure.

Kuramoto Y, Yamada T, Tamaki S, Okuyama Y, Morita T, Furukawa Y, Tanaka K, Iwasaki Y, Yasui T, Ueda H, Okada T, Kawasaki M, Levy WC, Komuro I, Fukunami M. Kuramoto Y, et al. Among authors: tamaki s. Am J Cardiol. 2011 Apr 15;107(8):1185-90. doi: 10.1016/j.amjcard.2010.12.019. Epub 2011 Feb 23. Am J Cardiol. 2011. PMID: 21349482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

869 results

Search Page

Filters